Insight Molecular Diagnostics corrects clerical error in bylaws exhibit

Insight Molecular Diagnostics Inc.

Company filed corrected Third Amended and Restated Bylaws to replace erroneous exhibit 3.5.
Original exhibit inadvertently included shareholder voting provisions not part of Bylaws.
No other disclosures in the 10-K changed.

item 8.01 item 9.01

Insight Molecular Diagnostics Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-020461

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.